Promoting Sustainable Prescribing—A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 20.06.2026. Verfasst von Björn Ericsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gävleborg Drug and Therapeutics Committee, Gävle, Sweden. Hauptthemen laut MEDLINE: Pharmacy and Therapeutics Committee, Drug Prescriptions, Practice Patterns, Physicians'. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala Universitet.
Abstract (Originalsprache)
During the past two decades, it has become evident that pharmaceuticals is an emerging environmental problem. In this study, we present the experiences from two Swedish Drug & Therapeutics Committees (DTCs) on how they integrate environmental considerations into their formularies and continuous professional education activities. A cross sectional study was performed describing activities to promote sustainable prescribing conducted during two decades by the DTCs in the Swedish regions of Gävleborg and Västernorrland, along with trends in sales of diclofenac and fluoroquinolones between 2000 and 2024. The two DTCs integrate environmental considerations in their formularies and continuous professional education activities. Further acitivities include monitoring of prescribing, dialogue with water suppliers and pharmacies, as well as information and communication to the general public. The total utilization of diclofenac for systemic use peaked with 127 kg in Gävleborg and 137 kg in Västernorrland in 2011, after which the amounts declined. The topical formulations were mainly sold as over‐the‐counter and increased until 2016, when it started to decline. The amounts of ciprofloxacin and norfloxacin increased until 2012 when they started to decline. This case study from two Swedish regions illustrates how environmental considerations can be incorporated into the DTC's mission to promote rational and responsible medication use. We believe it may be valuable for different stakeholders to show potential ways in how to promote a more sustainable use of medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gävleborg Drug and Therapeutics Committee, Gävle, Sweden.
- Västernorrland Drug and Therapeutics Committee, Härnösand, Sweden.
- Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
- Swedish Medical Products Agency, Uppsala, Sweden.
- Health and Medical Care Administration, Stockholm, Sweden.
ORCID-Profile: Björn Ericsson, Ulf Lindahl, Johanna Villén, Marmar Nekoro, Helena Ramström, Björn Wettermark
Förderung
- Uppsala Universitet
Zitieren
APA
Ericsson, B., Lindahl, U., Villén, J., Nekoro, M., Ramström, H., & Wettermark, B. (2026). Promoting Sustainable Prescribing—A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70279
Vancouver
Ericsson B, Lindahl U, Villén J, Nekoro M, Ramström H, Wettermark B. Promoting Sustainable Prescribing—A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70279
BibTeX
@article{Ericsson2026,
author = {Ericsson, Björn and Lindahl, Ulf and Villén, Johanna and Nekoro, Marmar and Ramström, Helena and Wettermark, Björn},
title = {Promoting Sustainable Prescribing—A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70279}
}
EUVIMED